Daniel B Carr

Title: The Innovations of Daniel B Carr

Introduction

Daniel B Carr is a notable inventor based in Chestnut Hill, MA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the formulation of analgesic compositions. With a total of 5 patents, Carr's work has the potential to impact pain management therapies.

Latest Patents

Carr's latest patents focus on formulations of low-dose diclofenac combined with beta-cyclodextrin. One of his inventions is directed to a pharmaceutical composition containing a unit dose of a diclofenac compound effective to induce analgesia, wherein the dose of the diclofenac compound is less than 75 mg, specifically ranging from about 18.75 mg to about 37.5 mg. This invention also includes methods for treating subjects in need of analgesia using these compositions. Another patent similarly addresses a formulation with a diclofenac dose of less than 10 mg, further emphasizing the innovative approaches Carr has taken in pain relief.

Career Highlights

Throughout his career, Carr has worked with reputable organizations such as New England Medical Center Hospitals, Inc. and New England Medical Hospitals, Inc. His experience in these institutions has likely contributed to his expertise in pharmaceutical innovations.

Collaborations

Carr has collaborated with notable colleagues, including Andrzej W Lipkowski and Curtis Wright. These partnerships have likely enriched his research and development efforts in the pharmaceutical field.

Conclusion

Daniel B Carr's contributions to pharmaceutical formulations demonstrate his commitment to advancing pain management solutions. His innovative patents reflect a deep understanding of the complexities involved in creating effective analgesic therapies.